Category Archives: Molecular Cardiology

The virus that causes COVID-19 was present in New York City long before the city's first case of the disease was confirmed on March 1, researchers at the Icahn School of Medicine at Mount Sinai report. Their study found that more than 1.7 million New Yorkers--about 20 percent of the city's population--have already been infected with the virus, known as SARS-CoV-2, and that the infection fatality rate of the virus is close to 1 percent, ten times deadlier than the flu. Results of the retrospective surveillance study of more than 10,000 plasma samples taken from the beginning of February to July will be published in Nature on Tuesday, November 3 at 5AM ET Continue reading →

November 02, 2020 06:12 ET | Source: Fortune Business Insights Pune, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The global digital PCR market size is forecast to reach USD 799.1 million by 2026, attributed to the increasing prevalence of infectious diseases and genetic disorders worldwide Continue reading →

November 02, 2020 05:16 ET | Source: Fortune Business Insights Pune, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The global dental prosthetics market size is predicted to reach USD 9.71 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period Continue reading →

At 20 years old, Auckland student Will Hewitt is already on the frontline in the fight against heart disease. Continue reading →

Read Time: A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has been in use for more than 40 years, has been found to have unique cardioprotective properties. Continue reading →

President Donald Trump was moved from the White House to Walter Reed medical center late Friday, the same day that he and first lady Melania Trump had tested positive for coronavirus. Continue reading →

Global In-Vitro Diagnostic market was valued at USD 59,272.87 million in 2018 and is estimated to be valued at USD 82,626.27 million in 2024, witnessing a CAGR of 4.81%. The growth of the global IVD market can be attributed to the high prevalence of chronic and infectious diseases Continue reading →

The nuclear medicine market is expected to exceed more than US$ 5.0 billion by 2024 growing at around 9.0% CAGR for the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Continue reading →

The report covers forecast and analysis for the Radiopharmaceutical Market on a global, regional and country level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on both volumes (million tons) and revenue (USD million). The study includes drivers and restraints for the Radiopharmaceutical market along with the impact they have on the demand over the forecast period Continue reading →

Cardiologist to the whos who of Houston for decades, Dr. James T Continue reading →